Arterial Events in Patients with Chronic Myeloid Leukemia Receiving Treatment with Second Generation Tyrosine Kinase Inhibitors

Arterial Events in Patients with Chronic Myeloid Leukemia Receiving Treatment with Second Generation Tyrosine Kinase Inhibitors

Target therapy of chronic myeloid leukemia (CML) by tyrosine kinase inhibitors (TKI) allows to achieve high rates of the overall survival in CML. The choice of TKI treatment in every particular case should be based on individual CML patient’s characteristics, including comorbidities and the risk of...

Full description

Saved in:
Bibliographic Details
Main Authors: GA Gusarova, AG Turkina
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2016-10-01
Series:Клиническая онкогематология
Subjects:
tyrosine kinase inhibitors
artery occlusion
atherosclerosis
pulmonary hypertension
Online Access:http://bloodjournal.ru/en/arterial-events-in-patients-with-chronic-myeloid-leukemia-receiving-treatment-with-second-generation-tyrosine-kinase-inhibitors/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://bloodjournal.ru/en/arterial-events-in-patients-with-chronic-myeloid-leukemia-receiving-treatment-with-second-generation-tyrosine-kinase-inhibitors/

Similar Items